Back to Results
First PageMeta Content
Gadopentetic acid / Magnetic resonance imaging / Gadodiamide / Gadolinium / Nephrogenic systemic fibrosis / Aspirin / Chemistry / Matter / Medicine


Public Assessment Report for paediatric studies submitted in accordance with Article 45 and 46 of Regulation (EC) No1901/2006, as amended Gadopentetic acid (Gadopentate) Magnevist
Add to Reading List

Document Date: 2014-04-01 10:51:04

Open Document

File Size: 1,63 MB

Share Result on Facebook

City

Magnevist / /

Company

MAH / /

Continent

Europe / /

Country

Poland / Norway / France / Japan / Austria / United States / Netherlands / Iceland / Portugal / Slovenia / United Kingdom / Cyprus / Latvia / Sweden / Finland / Spain / Greece / Denmark / /

Event

FDA Phase / /

Facility

Magnevist INN / /

Holiday

natal day / /

IndustryTerm

gadolinium containing products / pharmaceutical formulation / mmol/ml solution / spinal and whole body magnetic resonance imaging / medicinal product / contrast media / rubber stopper / medicinal products / /

MedicalCondition

recurrent tumours / Nausea / tumour / vomiting / Nephrogenic Systemic Fibrosis / metastases / /

Organization

National Science Foundation / FDA / Committee for Medicinal Products for Human Use / European Union / /

Position

EXECUTIVE / CONTENTS I. Executive / /

Product

Gadopentetate injections / Magnevist / Cyprus / /

Technology

pharmacokinetics / magnetic resonance imaging / transplantation / pdf / MRI / /

URL

http /

SocialTag